Firms/companies
Dr Reddy’s targets $1 bn revenue from generics
07 Mar 2011
The Hyderabad-based company, a leader in genetic drugs, sold $600 million worth of generics globally in the nine months of this fiscal ended 31 December
The Hyderabad-based company, a leader in genetic drugs, sold $600 million worth of generics globally in the nine months of this fiscal ended 31 December